1. 1105. Population Pharmacokinetic Analyses for Tebipenem After the Administration of Tebipenem Pivoxil Hydrobromide. (4th December 2021) Authors: Ganesan, Harish; Kumar, Vipul; Bhavnani, Sujata M; Melnick, David; Rubino, Christopher M Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S644 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1288. Phase 1 First-in-Human Single- and Multiple-Ascending Dose Trial Demonstrates Pharmacokinetics (PK) and Tolerability of SPR720, an Oral DNA GyrB Inhibitor for Mycobacterial Infections. (31st December 2020) Authors: Talley, Angela; Thurston, Archie; Moore, Grayson; Satterfield, Myriah M; Manyak, Erika L; Kumar, Vipul; Stokes, Suzanne; Dane, Aaron; Melnick, David Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Computational and in vitro experimental analyses of the anti-COVID-19 potential of Mortaparib and MortaparibPlus. Issue 10 (29th October 2021) Authors: Kumar, Vipul; Sari, Anissa Nofita; Meidinna, Hazna Noor; Dhanjal, Jaspreet Kaur; Subramani, Chandru; Basu, Brohmomoy; Kaul, Sunil C.; Vrati, Sudhanshu; Sundar, Durai; Wadhwa, Renu Journal: Bioscience reports Issue: Volume 41:Issue 10(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. COVID19-inhibitory activity of withanolides involves targeting of the host cell surface receptor ACE2: insights from computational and biochemical assays. Issue 17 (22nd November 2022) Authors: Kalra, Rajkumar Singh; Kumar, Vipul; Dhanjal, Jaspreet Kaur; Garg, Sukant; Li, Xiaoshuai; Kaul, Sunil C.; Sundar, Durai; Wadhwa, Renu Journal: Journal of biomolecular structure & dynamics Issue: Volume 40:Issue 17(2022) Page Start: 7885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Insights into the potential of withanolides as Phosphodiesterase-4 (PDE4D) inhibitors. Issue 6 (13th April 2023) Authors: Rathi, Aditya; Kumar, Vipul; Sundar, Durai Journal: Journal of biomolecular structure & dynamics Issue: Volume 41:Issue 6(2023) Page Start: 2108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Perceived severity, fear of retaliation, and suspect report intention of general public during COVID‐19 pandemic: A moderated moderation analysis. (5th August 2021) Authors: Das, Sitanshu Sekhar; Kumar, Vipul Journal: Journal of public affairs Issue: Volume 22(2022)Supplement 1 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. Issue 11 (24th July 2021) Authors: Kumar, Vipul; Dhanjal, Jaspreet Kaur; Kaul, Sunil C.; Wadhwa, Renu; Sundar, Durai Journal: Journal of biomolecular structure & dynamics Issue: Volume 39:Issue 11(2021) Page Start: 3842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. Issue 1 (2nd January 2022) Authors: Kumar, Vipul; Dhanjal, Jaspreet Kaur; Bhargava, Priyanshu; Kaul, Ashish; Wang, Jia; Zhang, Huayue; Kaul, Sunil C.; Wadhwa, Renu; Sundar, Durai Journal: Journal of biomolecular structure & dynamics Issue: Volume 40:Issue 1(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗